Bicara Therapeutics BCAX
NASDAQ BCAX
$17.57 -0.34 (-1.90%)
As of: Oct 22, 2026 · 2:39 PM EDT

Bicara Therapeutics (BCAX) Short-term Investments (2025 - 2026)

Updated

Bicara Therapeutics (BCAX) reported Short-term Investments of $400.66 million for Q2 2026, up 85.2% from the prior quarter.

Analysis

Bicara Therapeutics (BCAX) Short-term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Bicara Therapeutics posted Short-term Investments of $318.12 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $216.29 million (Q1 2026), $318.12 million (Q4 2025) and $118.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Bicara Therapeutics 1.19 Bn -549.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400.66 Mn
Mar 31, 2026 216.29 Mn
Dec 31, 2025 318.12 Mn
Sep 30, 2025 118.50 Mn
API Access

Bicara Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=BCAX&period=max&api_key=YOUR_API_KEY